A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Peking University Third Hospital, Beijing

The First Hospital of Jilin University, Changchun

The First Hospital of Harbin, Harbin

The First Affiliated Hospital of Soochow University, Suzhou

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin

The first Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

The First Affiliated Hospital of Wenzhou Medical College, Wenzhou

Fujian Medical University Union Hospital, Fuzhou

Union Hospital, Tongji Medical College of Huazhong University of Science & Technology, Wuhan

Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou

Guangzhou First People's Hospital, Guangzhou

NanFang Hospital of Southern Medical University, Guangzhou

Sun Yat-sen University Cancer Center, Guangzhou

West China Hospital of Sichuan University, Chengdu